Source: HSRL Blog

HSRL Blog Immunohistochemistry for Nonclinical Studies

IHC is a valuable tool that can be used during most phases of drug development. It assists with target validation during early discovery projects and can help determine efficacy and safety during later phases of research and development.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Tom Galati

CEO Approval Rating

70/100

Read more